Provided by Tiger Fintech (Singapore) Pte. Ltd.

Everus Construction Group, Inc.

48.82
+2.234.79%
Volume:182.81K
Turnover:8.75M
Market Cap:2.49B
PE:17.37
High:48.83
Open:47.40
Low:47.12
Close:46.59
Loading ...

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

GlobeNewswire
·
02 May

Press Release: Everus Construction Group to Hold First Quarter Results Webcast May 14

Dow Jones
·
01 May

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

Business Wire
·
29 Apr

Everus Construction Group Inc expected to post earnings of 43 cents a share - Earnings Preview

Reuters
·
26 Apr

BRIEF-Tim Sznewajs Joins Everus As Vice President Of Corporate Development And Strategy

Reuters
·
23 Apr

Tim Sznewajs Joins Everus as Vice President of Corporate Development and Strategy

Business Wire
·
23 Apr

OneMedNet and Protege Partner to Advance the Future of AI-Driven Healthcare with Real-Time, Multimodal Data

GlobeNewswire
·
23 Apr

Everus Construction Group Inc expected to post earnings of 43 cents a share - Earnings Preview

Reuters
·
23 Apr

Everus Construction Group Inc expected to post earnings of 43 cents a share - Earnings Preview

Reuters
·
19 Apr

Everus Construction Group Inc expected to post earnings of 43 cents a share - Earnings Preview

Reuters
·
16 Apr

Everus Construction Group Inc expected to post earnings of 43 cents a share - Earnings Preview

Reuters
·
12 Apr

3 Undervalued Small Caps With Insider Buying Opportunities

Simply Wall St.
·
10 Apr

Everus Construction Group Inc expected to post earnings of 43 cents a share - Earnings Preview

Reuters
·
09 Apr

Here's Why Everus Construction Group (NYSE:ECG) Can Manage Its Debt Responsibly

Simply Wall St.
·
08 Apr

Class Action Filed Against Everus Construction Group, Inc. (ECG) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP

TIPRANKS
·
08 Apr

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

GlobeNewswire
·
05 Apr

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

Business Wire
·
14 Mar

As Trump slump hits investors, why does big business still love him?

The Sydney Morning Herald
·
04 Mar

Everus to Participate in Cantor Global Technology Conference

Business Wire
·
04 Mar

Everus Construction Group Inc : Oppenheimer Cuts Target Price to $60 From $80

THOMSON REUTERS
·
27 Feb